Try our Advanced Search for more refined results
Searching dockets in Biomarin Pharmaceutical Inc x
Alert me of new activity
All Case Activity Alerts Include: Answers, Appeals, Complaints, Motions, Orders, Trial Notes
Patent - Abbreviated New Drug Application(ANDA) | New Jersey
Text Order
TEXT ORDER: Having received and reviewed the parties' August 20, 2026 joint letter requesting adjournment of the August 25, 2026 status conference, ECF No. 47; and the Court noting that discovery is progressing and no issues require the Court's attention; and for good cause shown, it is hereby ORDERED that the parties' request is GRANTED and the August 25, 2026 status conference is ADJOURNED. The Court will conduct a telephone status conference on November 3, 2026, at 10:00 a.m. Counsel shall dial 1-856-210-8988, access code 991982179# to connect to the call. So Ordered by Magistrate Judge Elizabeth A. Pascal on 08/21/2026. (eap)
Letter
Letter from William P. Deni, Jr. to the Honorable Elizabeth A. Pascal, U.S.M.J. requesting adjournment of status conference. (DENI, WILLIAM)
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login
Email (NOTE: Free email domains not supported)
First Name
Last Name
Job Title
Phone
PLEASE NOTE: A verification email will be sent to your address before you can access your trial.
Password (at least 8 characters required)
Confirm Password
Law360 UK may contact you in your professional capacity with information about our other products, services and events that we believe may be of interest.You’ll be able to update your communication preferences via the unsubscribe link provided within our communications.We take your privacy seriously. Please see our Privacy Policy.